Thomas Rüediger

1.3k total citations
15 papers, 668 citations indexed

About

Thomas Rüediger is a scholar working on Pathology and Forensic Medicine, Oncology and Dermatology. According to data from OpenAlex, Thomas Rüediger has authored 15 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 6 papers in Oncology and 5 papers in Dermatology. Recurrent topics in Thomas Rüediger's work include Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (5 papers) and CAR-T cell therapy research (3 papers). Thomas Rüediger is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (5 papers) and CAR-T cell therapy research (3 papers). Thomas Rüediger collaborates with scholars based in Germany, United States and Italy. Thomas Rüediger's co-authors include Peter Reimer, Martin Wilhelm, Florian Weißinger, Hans‐Peter Tony, Susanne Eckstein, Volker Kunzmann, Eva Geissinger, Kerstin Schaefer‐Eckart, Matthias Eck and Manfred Smetak and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Surgical Pathology.

In The Last Decade

Thomas Rüediger

15 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Rüediger Germany 7 420 316 87 79 61 15 668
Junsik Park South Korea 11 218 0.5× 263 0.8× 30 0.3× 41 0.5× 78 1.3× 59 532
Marc Boisvert United States 17 342 0.8× 352 1.1× 36 0.4× 25 0.3× 197 3.2× 32 827
Marco Campoli Italy 8 287 0.7× 198 0.6× 39 0.4× 63 0.8× 106 1.7× 19 466
Jing‐Zhou Hou United States 14 503 1.2× 332 1.1× 34 0.4× 128 1.6× 232 3.8× 59 967
Riccardo Turrini Italy 12 205 0.5× 282 0.9× 91 1.0× 74 0.9× 81 1.3× 18 445
Amanda R. Perry United Kingdom 11 237 0.6× 208 0.7× 37 0.4× 311 3.9× 172 2.8× 13 726
R. Handgretinger Germany 15 226 0.5× 222 0.7× 106 1.2× 43 0.5× 228 3.7× 33 718
Emily Curran United States 16 263 0.6× 201 0.6× 27 0.3× 69 0.9× 278 4.6× 42 765
Reinhard Marks Germany 15 179 0.4× 301 1.0× 38 0.4× 194 2.5× 136 2.2× 55 793
Martin Schwonzen Germany 13 124 0.3× 238 0.8× 20 0.2× 113 1.4× 106 1.7× 27 510

Countries citing papers authored by Thomas Rüediger

Since Specialization
Citations

This map shows the geographic impact of Thomas Rüediger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Rüediger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Rüediger more than expected).

Fields of papers citing papers by Thomas Rüediger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Rüediger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Rüediger. The network helps show where Thomas Rüediger may publish in the future.

Co-authorship network of co-authors of Thomas Rüediger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Rüediger. A scholar is included among the top collaborators of Thomas Rüediger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Rüediger. Thomas Rüediger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Fogt, Franz, Thomas Rüediger, Albert J. Augustin, et al.. (2019). Isolated Intraocular Rosai-Dorfman Disease. Ocular Oncology and Pathology. 5(6). 418–423. 3 indexed citations
2.
Yorke, Amy M., et al.. (2016). Doctor of physical therapy students’ attitudes towards people with disabilities: a descriptive study. Disability and Rehabilitation. 39(1). 91–97. 16 indexed citations
3.
Wilhelm, Martin, Manfred Smetak, Peter Reimer, et al.. (2016). First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer Journal. 6(7). e452–e452. 50 indexed citations
4.
Smith, Laura, et al.. (2016). PERFORMANCE OF HIGH SCHOOL FOOTBALL PLAYERS ON CLINICAL MEASURES OF DEEP CERVICAL FLEXOR ENDURANCE AND CERVICAL ACTIVE RANGE OF MOTION: IS HISTORY OF CONCUSSION A FACTOR?. PubMed. 11(2). 156–63. 3 indexed citations
5.
Rüediger, Thomas, Stephen Allison, Joseph Moore, & Robert S. Wainner. (2014). Reliability, reference values and predictor variables of the ulnar sensory nerve in disease free adults. Neurophysiologie Clinique. 44(3). 281–289. 1 indexed citations
6.
Lester, M., et al.. (2013). Effect of Specific Short-Term Physical Training on Fitness Measures in Conditioned Men. The Journal of Strength and Conditioning Research. 28(3). 679–688. 20 indexed citations
7.
Minckwitz, Gϋnter von, Jens‐Uwe Blohmer, Manfred Kaufmann, et al.. (2012). Prognostic and predictive impact of Ki-67 before and after neoadjuvant chemotherapy on PCR and survival: Results of the GeparTrio trial.. Journal of Clinical Oncology. 30(15_suppl). 1023–1023. 6 indexed citations
8.
Federico, Massimo, Monica Bellei, Emanuela Pesce, et al.. (2009). T-Cell Project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma. Revista Brasileira de Hematologia e Hemoterapia. 31. 4 indexed citations
9.
Horn, Lars‐Christian, Anja Reichert, Marcus J. Trunk, et al.. (2008). Immunostaining for p16INK4a Used as a Conjunctive Tool Improves Interobserver Agreement of the Histologic Diagnosis of Cervical Intraepithelial Neoplasia. The American Journal of Surgical Pathology. 32(4). 502–512. 75 indexed citations
10.
Rüediger, Thomas, Bertrand Coiffier, Dennis D. Weisenburger, & Massimo Federico. (2006). International T-Cell Lymphoma Classification Project: Angioimmunoblastic T-Cell Lymphoma.. Blood. 108(11). 2052–2052. 1 indexed citations
11.
Reimer, Peter, Thomas Rüediger, Florian Weißinger, et al.. (2006). Different Outcome for Angioimmunoblastic T-Cell Lymphoma (AIL) and Peripheral T-Cell Lymphoma Unspecified (PTCL-U) Following Upfront Autologous Stem Cell Transplantation.. Blood. 108(11). 5431–5431. 3 indexed citations
12.
Reimer, Peter, Thomas Rüediger, Eva Geissinger, et al.. (2005). Autologous Stem Cell Transplantation as First-Line Therapy in Peripheral T-Cell Lymphomas. A Prospective Multicenter Study.. Blood. 106(11). 2074–2074. 10 indexed citations
13.
Reimer, Peter, Thomas Rüediger, Eva Geissinger, et al.. (2004). Autologous Stem Cell Transplantation as First Line Therapy in Peripheral T Cell Lymphomas. Update of a Prospective Multicenter Study.. Blood. 104(11). 904–904. 3 indexed citations
14.
Wilhelm, Martin, Volker Kunzmann, Susanne Eckstein, et al.. (2003). γδ T cells for immune therapy of patients with lymphoid malignancies. Blood. 102(1). 200–206. 468 indexed citations
15.
Gill, Norman W., Thomas Rüediger, Josef H. Moore, et al.. (1999). Test-retest reliability of the ulnar F-wave minimum latency in normal adults.. PubMed. 39(4). 195–200. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026